Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13.8M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
1.07M
-
Shares change
-
+1.07M
-
Total reported value, excl. options
-
$2.08M
-
Value change
-
+$2.08M
-
Number of buys
-
17
-
Price
-
$1.95
Significant Holders of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) as of Q4 2022
18 filings reported holding COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share as of Q4 2022.
Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.07M shares
of 13.8M outstanding shares and own 7.71% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (421K shares), VANGUARD GROUP INC (271K shares), RENAISSANCE TECHNOLOGIES LLC (114K shares), BlackRock Inc. (74.1K shares), GEODE CAPITAL MANAGEMENT, LLC (69.5K shares), MORGAN STANLEY (44.7K shares), STATE STREET CORP (24.4K shares), Parallel Advisors, LLC (15.2K shares), NORTHERN TRUST CORP (12.2K shares), and BANK OF AMERICA CORP /DE/ (8.99K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.